Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1

Recent cardiovascular outcome trials found that sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce cardiovascular disease and mortality in type 2 diabetic patients; however, the underlying mechanisms are not fully known. Since the proliferation and migration of vascular smooth muscle cells (SM...

Descripción completa

Detalles Bibliográficos
Autores principales: Behnammanesh, Ghazaleh, Durante, Giovanna L., Khanna, Yash P., Peyton, Kelly J., Durante, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152682/
https://www.ncbi.nlm.nih.gov/pubmed/32278282
http://dx.doi.org/10.1016/j.redox.2020.101527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152682/
https://www.ncbi.nlm.nih.gov/pubmed/32278282
http://dx.doi.org/10.1016/j.redox.2020.101527

Ejemplares similares